<DOC>
	<DOCNO>NCT00483158</DOCNO>
	<brief_summary>The purpose study study safety single dose multiple dos Finafloxacin hydrochloride healthy volunteer . The level Finafloxacin hydrochloride measure subject blood urine . One part study ass Finafloxacin hydrochloride eradicate Helicobacter pylorus , stomach bacteria . Another part study assess activity drug urine .</brief_summary>
	<brief_title>First Time Man Study Finafloxacin Hydrochloride</brief_title>
	<detailed_description>New antibiotic need due increase resistance bacteria exist antibiotic . Helicobacter pylorus ( H. pylorus ) bacteria stomach show cause peptic ulcer implicate gastric cancer . Up 40 % population H. pylorus . Current treatment use eradicate H. pylorus combination number drug include antibiotic drug reduce acid stomach . These treatment complicate H. pylorus resistant antibiotic use . This study first use Finafloxacin hydrochloride man examine safety make preliminary study effectiveness single agent eradicate H. pylorus . The urine subject also use test effectiveness kill bacteria cause urinary tract infection .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<criteria>Male female healthy subject 1855 year age In good health For part C , Helicobacter pylori carrier status assess positive result urease breath test screening . Abnormal physical finding clinical significance Screening examination baseline would interfere objective study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Helicobacter pylorus</keyword>
	<keyword>Fluoroquinolones</keyword>
	<keyword>First Man</keyword>
</DOC>